CliffBio
biologic

Xyntha, Xyntha Solofuse

Antihemophilic Factor (Recombinant), Plasma/Albumin Free

Loss of exclusivity—loss of exclusivity
CompanyWyeth →See this company's full patent-cliff portfolio

Drug detail

Brand nameXyntha, Xyntha Solofuse
Active ingredientAntihemophilic Factor (Recombinant), Plasma/Albumin Free
Strength2000IU
Dosage formFor Injection
RouteIntravenous
ModalityBiologic
Marketing statusRx

More from Wyeth

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.